Candel Therapeutics (CADL) Prices 9M Share IPO at $8/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Candel Therapeutics (CADL) IPO Opens Flat
July 27, 2021 11:22 AM EDTToday's IPO for Candel Therapeutics, Inc. (NASDAQ: CADL) opened for trading at $8 after pricing 9,000,000 shares of common stock at a public offering price of $8.00 per share.
Jefferies, Credit Suisse, BMO Capital Markets and UBS Investment Bank are acting as joint book-running... More
